Verici Dx plc (VRCI) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Verici Dx Plc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.777 Good afternoon and welcome to the Verici DX PLC Business Update. 00:00:03.777 -- 00:00:06.361 Throughout the recorded update, investors will be in listen-only mode. 00:00:06.361 -- 00:00:09.646 Questions are encouraged and can be submitted at any time by the Q&A tab situated in 00:00:09.646 -- 00:00:13.652 the right-hand corner of your screen. Simply type in your questions and press send. 00:00:13.652 -- 00:00:16.296 The company may not be in a position to answer every question it receives during the 00:00:16.296 -- 00:00:19.661 meeting itself. However, the company can review all the questions submitted today and 00:00:19.661 -- 00:00:22.325 publish responses where it is appropriate to do so. 00:00:22.325 -- 00:00:25.189 Before we begin, I'd like to submit the following poll. 00:00:25.189 -- 00:00:28.952 I'd now like to hand you over to CEO, Sarah. 00:00:32.903 -- 00:00:38.269 Welcome everybody. Thanks for attending. This is the half year results 00:00:38.269 -- 00:00:41.192 and business update. 00:00:41.192 -- 00:00:44.813 Obviously there is our disclosure slide. 00:00:50.201 -- 00:00:56.187 I'd like to kick off by presenting the slide that I have presented before and 00:00:56.187 -- 00:01:01.393 then showing how we are translating this into our current view 00:01:01.393 -- 00:01:06.440 of the business. This has been our vision slide for how we operate with 00:01:06.440 -- 00:01:11.126 the company. You can see the kidney transplant testing, 00:01:11.126 -- 00:01:16.374 the suite of products being pre-transplant for Arthur, early 00:01:16.374 -- 00:01:21.541 stage damage, post-transplant to tibia, late stage 00:01:21.541 -- 00:01:23.123 Protega. 00:01:23.123 -- 00:01:28.490 Collectively, those three tests have covered the end-to-en...